RESEDA, CA - March 19, 2026 - PRESSADVANTAGE - Moment of Clarity has published a comprehensive new educational resource ...

Oceanside, CA - March 18, 2026 - PRESSADVANTAGE - Moment of Clarity has released a new educational resource examining ...

GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness ...

The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder. Rejoyn, made by Otsuka Pharmaceutical and Click Therapeutics, ...

Depression-related fatigue is caused by cellular "overworking" at rest and a failure to produce energy under stress.

Additionally, some patients report distressing withdrawal symptoms when they try to stop, such as insomnia, anxiety, and ...

A landmark paper published in Lancet Psychiatry—the largest-ever review of the safety and efficacy of cannabinoids across a ...

Researchers have suggested it may not be effective in treating some of the most common conditions it’s prescribed for.

Postpartum depression can last months, even with treatment, depending on the individual. However, it may last for years ...

(Anastassiya Bezhekeneva/Getty Images) A large umbrella review has found no strong evidence to date that medicinal cannabis ...

People frequently use medical cannabis to treat anxiety, depression and PTSD, but two new reviews show there is little ...

People with psoriasis prescribed bimekizumab have no greater risk for major depressive disorder or suicidal ideation than ...